HomeCompareVIG vs EW

VIG vs EW: Dividend Comparison 2026

VIG yields 1.64% · EW yields 2.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIG wins by $8.9K in total portfolio value
10 years
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →
EW
EW
● Live price
2.52%
Share price
$79.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$295.93
Full EW calculator →

Portfolio growth — VIG vs EW

📍 VIG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIGEW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIG + EW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIG pays
EW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
EW
Annual income on $10K today (after 15% tax)
$213.84/yr
After 10yr DRIP, annual income (after tax)
$251.54/yr
At 15% tax rate, EW beats the other by $99.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIG + EW for your $10,000?

VIG: 50%EW: 50%
100% EW50/50100% VIG
Portfolio after 10yr
$27.9K
Annual income
$237.54/yr
Blended yield
0.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EW right now

VIG
No analyst data
EW
Analyst Ratings
32
Buy
16
Hold
Consensus: Buy
Price Target
$96.38
+21.2% upside vs current
Range: $87.00 — $110.00
Altman Z
10.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIG buys
0
EW buys
0
No recent congressional trades found for VIG or EW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIGEW
Forward yield1.64%2.52%
Annual dividend / share$3.45$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$32.4K$23.4K
Annual income after 10y$179.15$295.93
Total dividends collected$1.7K$2.8K
Payment frequencyquarterlyquarterly
SectorETFHealthcare

Year-by-year: VIG vs EW ($10,000, DRIP)

YearVIG PortfolioVIG Income/yrEW PortfolioEW Income/yrGap
1← crossover$11,304$163.92$10,952$251.57+$352.00VIG
2$12,759$166.33$11,976$257.49+$783.00VIG
3$14,382$168.52$13,077$263.14+$1.3KVIG
4$16,192$170.52$14,261$268.55+$1.9KVIG
5$18,210$172.34$15,533$273.70+$2.7KVIG
6$20,460$173.98$16,899$278.61+$3.6KVIG
7$22,968$175.48$18,365$283.28+$4.6KVIG
8$25,763$176.83$19,938$287.72+$5.8KVIG
9$28,878$178.05$21,626$291.93+$7.3KVIG
10$32,350$179.15$23,436$295.93+$8.9KVIG

VIG vs EW: Complete Analysis 2026

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →

EWHealthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Full EW Calculator →
📬

Get this VIG vs EW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIG vs DGROVIG vs SCHDVIG vs NOBLVIG vs VYMVIG vs DGRWVIG vs JEPIVIG vs OVIG vs KO

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.